ArticleProceedings. IEEE International Conference on Healthcare Informatics2023
Designing Software for Genomics Medicine Service Leaders to Engage Stakeholders.
Article in Proceedings. IEEE International Conference on Healthcare Informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Stakeholder engagement can be challenging yet is critically important for the success of a new genomic medicine service or genetic test offering. Services may include ordering, analysis, interpretation, and counseling associated with using a patient's genetic information to make decisions about medical choices. Objective: The aim of this study was to use a human-centered design (HCD) approach to design software for genomic medicine service leaders seeking to engage stakeholders. Of particular interest were stakeholders that could be partners to champion a new genetic test offering. Methods: Our HCD process was driven by a modified design sprint methodology involving participatory design sessions and semi-structured interviews with experts. Subsequently, we created a low-fidelity prototype aiming to facilitate early engagement with potential genomic medicine service partners. The prototype was used to test the design with current genomic medicine service leaders. To guide our evaluation, we developed a set of design considerations for the software application that reflected common strategies used by programs successfully implementing genetic test offerings in diverse settings. Results: We analyzed notes collected from interview sessions with seven genomic medicine service leaders. We identified ten sub-themes, synthesized corresponding notes, and focused our interpretations around three design considerations: #1-identify potential genomic medicine service partners to champion a new genetic test offering; #2-train and educate stakeholders; and #3-obtain and use genomic medicine partner feedback. The top three ranked sub-themes were: 1 - add new information, 2 - general approval, and 3 - add/change functionality. Conclusion: Our findings suggest that genomic medicine service leaders approve of our software design and process to facilitate key stakeholders' review and endorsement of a new genetic test offering. We also demonstrated an evaluation strategy that draws from lessons of successful genomic medicine programs to identify and prioritize areas to improve the software in future design iterations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.